Compulsory License Application filed against AstraZeneca’s “SAXAGLIPTIN”
July 8, 2015
Misuse of Trademark on Websites
Maggi Unsafe only for Indians?
On June 23, 2015, Jubilant Life Sciences Ltd. received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration
INDIA: Conflict and Ruling on Bonafide Use of Acronym as Trademark
June 17, 2015
INDIA: Opposition Against Gilead’s Patent Application for Hepatitis C drug “Sovaldi”